Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression

Information

  • Research Project
  • 8905520
  • ApplicationId
    8905520
  • Core Project Number
    R44MH107065
  • Full Project Number
    1R44MH107065-01
  • Serial Number
    107065
  • FOA Number
    PAR-14-088
  • Sub Project Id
  • Project Start Date
    4/1/2015 - 9 years ago
  • Project End Date
    3/31/2017 - 7 years ago
  • Program Officer Name
    HAIM, ADAM
  • Budget Start Date
    4/1/2015 - 9 years ago
  • Budget End Date
    3/31/2016 - 8 years ago
  • Fiscal Year
    2015
  • Support Year
    01
  • Suffix
  • Award Notice Date
    3/31/2015 - 9 years ago
Organizations

Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression

? DESCRIPTION (provided by applicant): Mood disorders tend to have some of the highest prevalence rates among mental health disorders, and enact high personal, social and economic costs in our country and around the world, presenting a significant public health challenge. Patients often experience low rates of care, worsening their own outcomes. Cogito's mobile application Cogito Companion objectively measures behavioral biomarkers via mobile phone sensors and uses these patterns as inputs to predictive models, trained against clinical outcomes. The models predict mental state components of mood disorders. The primary goal of this proposal is to validate the ability of Cogito Companion to passively detect changes in mood disorders in order to improve diagnosis, predict relapse, and measure disease progression in a national sample. This proposal addresses the critical barrier of accurate, objective real-time information on individual mental health. This barrier has prevented individuals from tracking their own disease progression and relapse, from empowering patients to self-manage their chronic symptoms, and from allowing individuals to know when to reach out and access healthcare support. The validation described in this grant proposal will provide patients the ability to have objective, transparent, and continuous metrics of their own mental health. These metrics have never before been available to the patient, in real-time, and with no bias of self -report. Through an observational study of the PCORI-funded and Massachusetts General Hospital-administered Mood Patient Powered Research Network participants, results will be gathered on the relationship of the biomarkers to clinical outcomes. This validation will lead to a successful Phase III commercialization of the technology.

IC Name
NATIONAL INSTITUTE OF MENTAL HEALTH
  • Activity
    R44
  • Administering IC
    MH
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    748202
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    242
  • Ed Inst. Type
  • Funding ICs
    NIMH:748202\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    COGITO HEALTH, INC.
  • Organization Department
  • Organization DUNS
    800035102
  • Organization City
    Boston
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    021094100
  • Organization District
    UNITED STATES